Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy

Somatic copy number alterations (SCNA), which are widespread in cancer, can predict the efficacy of immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC). However, the usefulness of SCNA for predicting the survival of patients treated with cytokine-induced killer (CIK) cells or chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Fan, Wu, Lei, Zhu, Ye, Li, Baihui, Huang, Ziqi, Ren, Xiubao, Yang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395268/
https://www.ncbi.nlm.nih.gov/pubmed/35022521
http://dx.doi.org/10.1038/s41417-021-00422-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395268/
https://www.ncbi.nlm.nih.gov/pubmed/35022521
http://dx.doi.org/10.1038/s41417-021-00422-5

Ejemplares similares